Manerba M - Search Results

1

NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases.

Di Stefano G, Manerba M, Vettraino M. Di Stefano G, et al. Among authors: manerba m. Curr Top Med Chem. 2013;13(23):2918-29. doi: 10.2174/15680266113136660207. Curr Top Med Chem. 2013. PMID: 24171774 Review.

2

Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.

Vettraino M, Manerba M, Govoni M, Di Stefano G. Vettraino M, et al. Among authors: manerba m. Anticancer Drugs. 2013 Sep;24(8):862-70. doi: 10.1097/CAD.0b013e328363ae50. Anticancer Drugs. 2013. PMID: 23797802

3

Inhibition of lactate dehydrogenase activity as an approach to cancer therapy.

Fiume L, Manerba M, Vettraino M, Di Stefano G. Fiume L, et al. Among authors: manerba m. Future Med Chem. 2014 Mar;6(4):429-45. doi: 10.4155/fmc.13.206. Future Med Chem. 2014. PMID: 24635523 Review.

4

Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.

Fiume L, Manerba M, Vettraino M, Di Stefano G. Fiume L, et al. Among authors: manerba m. Pharmacology. 2010;86(3):157-62. doi: 10.1159/000317519. Epub 2010 Aug 10. Pharmacology. 2010. PMID: 20699632

5

Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors.

Fiume L, Vettraino M, Manerba M, Di Stefano G. Fiume L, et al. Among authors: manerba m. Pharmacol Res. 2011 Apr;63(4):328-34. doi: 10.1016/j.phrs.2010.12.005. Epub 2010 Dec 17. Pharmacol Res. 2011. PMID: 21168502

6

Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells.

Fiume L, Manerba M, Vettraino M, Di Stefano G. Fiume L, et al. Among authors: manerba m. Eur J Pharmacol. 2011 Nov 16;670(1):39-43. doi: 10.1016/j.ejphar.2011.08.038. Epub 2011 Sep 10. Eur J Pharmacol. 2011. PMID: 21924262

7

Galloflavin (CAS 568-80-9): a novel inhibitor of lactate dehydrogenase.

Manerba M, Vettraino M, Fiume L, Di Stefano G, Sartini A, Giacomini E, Buonfiglio R, Roberti M, Recanatini M. Manerba M, et al. ChemMedChem. 2012 Feb 6;7(2):311-7. doi: 10.1002/cmdc.201100471. Epub 2011 Nov 4. ChemMedChem. 2012. PMID: 22052811

8

Albumin-drug conjugates in the treatment of hepatic disorders.

Fiume L, Manerba M, Di Stefano G. Fiume L, et al. Among authors: manerba m. Expert Opin Drug Deliv. 2014 Aug;11(8):1203-17. doi: 10.1517/17425247.2014.913567. Epub 2014 Apr 29. Expert Opin Drug Deliv. 2014. PMID: 24773257 Review.

9

Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors.

Rupiani S, Buonfiglio R, Manerba M, Di Ianni L, Vettraino M, Giacomini E, Masetti M, Falchi F, Di Stefano G, Roberti M, Recanatini M. Rupiani S, et al. Among authors: manerba m. Eur J Med Chem. 2015 Aug 28;101:63-70. doi: 10.1016/j.ejmech.2015.06.028. Epub 2015 Jun 18. Eur J Med Chem. 2015. PMID: 26114812

10

Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment.

Di Stefano G, Manerba M, Di Ianni L, Fiume L. Di Stefano G, et al. Among authors: manerba m. Future Med Chem. 2016 Apr;8(6):713-25. doi: 10.4155/fmc.16.10. Epub 2016 Apr 7. Future Med Chem. 2016. PMID: 27054686 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters